Literature DB >> 19231615

Phospholipase A2 inhibitors in atherosclerosis: the race is on.

Marshall A Corson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19231615     DOI： 10.1016/S0140-6736(09)60378-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2).

Authors:  Carmen A Peralta; Ronit Katz; Michael Shlipak; Ruth Dubin; Ian DeBoer; Nancy Jenny; Annette Fitzpatrick; Carol Koro; Bryan Kestenbaum; Joachim Ix; Mark Sarnak; Mary Cushman
Journal:  Am J Nephrol       Date:  2011-11-01       Impact factor: 3.754

2.  Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Authors:  Alexander Thompson; Pei Gao; Lia Orfei; Sarah Watson; Emanuele Di Angelantonio; Stephen Kaptoge; Christie Ballantyne; Christopher P Cannon; Michael Criqui; Mary Cushman; Albert Hofman; Chris Packard; Simon G Thompson; Rory Collins; John Danesh
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

3.  Associations between four types of single-nucleotide polymorphisms in PLA2G7 gene and clinical atherosclerosis: a meta-analysis.

Authors:  Anwar Santoso; Rido Maulana; Fatimah Alzahra; Irma Maghfirah; Agnes Dinar Putrinarita; Teuku Heriansyah
Journal:  Am J Cardiovasc Dis       Date:  2017-12-20

4.  Inflammation and atherosclerosis: disease modulating therapies.

Authors:  Mahesh J Patel; Michael A Blazing
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-12

Review 5.  Lipoquality control by phospholipase A2 enzymes.

Authors:  Makoto Murakami
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

Review 6.  Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development.

Authors:  Praveen P N Rao; Saad N Kabir; Tarek Mohamed
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-14

Review 7.  Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.

Authors:  Fabian Linden; Gabriele Domschke; Christian Erbel; Mohammadreza Akhavanpoor; Hugo A Katus; Christian A Gleissner
Journal:  Front Physiol       Date:  2014-11-21       Impact factor: 4.566

Review 8.  Updating Phospholipase A2 Biology.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshitaka Taketomi
Journal:  Biomolecules       Date:  2020-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.